PMID: 7529103Oct 1, 1994Paper

The use of nebulized opioids for breathlessness: a chart review

Palliative Medicine
M FarncombeA Gillin

Abstract

Breathlessness secondary to both cancer and non-malignant disease is a distressing, exhausting symptom which, to date, has been difficult to control. This paper reports a chart review undertaken on patients referred to the Ottawa Civic Hospital's Palliative Care Service over the 18-month period from 1 January 1992 to 30 June 1993. The intent of the review was to assess the recorded efficacy and safety of nebulized opioid use on patients with complaints of dyspnoea. Fifty-four patients were treated and subjective data have been compiled. The treatment was found to be effective, safe and convenient for the majority of the patients studied. In addition, nebulized opioids have been demonstrated as a treatment modality which is feasible for self-administration by the patient at home.

References

Oct 1, 1990·Journal of Pain and Symptom Management·K Cowcher, G W Hanks
Dec 1, 1990·Journal of Pain and Symptom Management·E BrueraR N MacDonald
Dec 10, 1988·BMJ : British Medical Journal·S Hughes, P M Calverley
Feb 1, 1986·Chest·D B Reuben, V Mor
May 1, 1994·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M Farncombe, S Chater
May 1, 1993·Journal of Pain and Symptom Management·M Farncombe, S Chater

❮ Previous
Next ❯

Citations

Mar 1, 1997·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·M Farncombe
Feb 18, 1998·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·E Lang, R Jedeikin
Oct 12, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Katri Elina Clemens, Eberhard Klaschik
Jun 28, 2000·Journal of Pain and Symptom Management·J P JanssensV Titelion
Feb 15, 2002·Journal of Pain and Symptom Management·Patrick J CoyneThomas J Smith
Dec 7, 2006·Pain Practice : the Official Journal of World Institute of Pain·S K ReddyN Gouondraj
Mar 18, 2000·Japanese Journal of Clinical Oncology·K TanakaY Nishiwaki
Apr 1, 1997·Thorax·S Ahmedzai, C Davis
Jan 5, 1999·American Journal of Respiratory and Critical Care Medicine
Apr 9, 2008·American Journal of Respiratory and Critical Care Medicine·Paul N LankenUNKNOWN ATS End-of-Life Care Task Force
Dec 1, 2007·International Journal of Chronic Obstructive Pulmonary Disease·Hope E UronisAmy P Abernethy
Jun 19, 2001·Cancer Investigation·J D'Olimpio
Feb 26, 2000·Clinical Journal of Oncology Nursing·M E Haisfield-Wolfe
Feb 11, 2004·Chest·Pamela A ForalDaniel E Hilleman
Jun 2, 1998·Cancer Treatment Reviews·C RipamontiE Bruera
Oct 31, 2006·Advanced Drug Delivery Reviews·Stephen J Farr, Babatunde A Otulana
Apr 9, 2005·Seminars in Oncology·Jamie H Von Roenn, Judith A Paice
Nov 5, 1997·Clinics in Chest Medicine·J Hansen-Flaschen
Jun 11, 2014·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Jackelyn Y BoydenJ Cameron Muir
May 18, 2004·Oncology Nursing Forum·Margaret JoyceJosephine Hawkins
Jul 2, 2005·Oncology Nursing Forum·Peeranuch Jantarakupt, Davina Porock
Jul 1, 1997·Palliative Medicine·G Zeppetella
Apr 1, 1995·Palliative Medicine·R D MacLeodM Potter
Apr 1, 1995·Palliative Medicine·C L Davis
Apr 23, 2010·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Don HayesHubert O Ballard
Jul 9, 2017·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Titilola M AfolabiVinita Pai
Sep 9, 2006·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Mary Beth ShirkJill Shirvani
Nov 24, 2017·The European Respiratory Journal·Cindy A VerberktDaisy J A Janssen
Mar 12, 2002·The American Journal of Hospice & Palliative Care·N SarhillM K Stahley
Mar 23, 1999·The American Journal of Hospice & Palliative Care·S Chandler
Dec 29, 1998·The American Journal of Hospice & Palliative Care·G Zeppetella
Dec 29, 1998·The American Journal of Hospice & Palliative Care·S G Mercadante
Mar 1, 1997·The American Journal of Hospice & Palliative Care·W M Stein, Y K Min
Mar 15, 2016·Anesthesia and Analgesia·Tatjana BevansDerek J Sakata
Jul 23, 1999·Current Opinion in Oncology·S B LeGrand, D Walsh
Jan 1, 1997·The Hospice Journal·P A SloanD A Sloan
May 15, 2002·The American Journal of Nursing·Christine Giska Westphal, Margaret L Campbell
Jun 6, 2000·The Hospice Journal·J C MuirC F von Gunten
Feb 15, 1997·Medizinische Klinik·B Knupp, W Stille
Feb 8, 2000·The American Journal of Hospice & Palliative Care·S Baumrucker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.